Passive immunotherapy with dromedary immune serum in an experimental animal model for middle east respiratory syndrome coronavirus infection

Journal of Virology

Volumn 89, Issue 11, 2015, Pages 6117-6120

  Zhao, Jincun ^a,e   Perera, Ranawaka A P M ^b   Kayali, Ghazi ^c   Meyerholz, David ^d   Perlman, Stanley ^a   Peiris, Malik ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORONAVIRUS INFECTION; DISEASE SEVERITY; DROMEDARY; DRUG EFFICACY; EXPERIMENTAL ANIMAL; FEMALE; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; LUNG INFECTION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS LOAD; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CAMEL; CORONAVIRUS INFECTIONS; DISEASE MODEL; IMMUNOLOGY; LUNG; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

ANIMALIA; CAMELIDAE; CAMELUS DROMEDARIUS; CORONAVIRUS;

ANIMALS; CAMELUS; CORONAVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SERA; IMMUNIZATION, PASSIVE; LUNG; MICE, INBRED BALB C; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; TREATMENT OUTCOME;

EID: 84929619188     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00446-15     Document Type: Article

References (25)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814-1820. http://dx.doi.org/10.1056/NEJMoa1211721.
2. Drosten C, Meyer B, Muller MA, Corman VM, Al-Masri M, Hossain R, Madani H, Sieberg A, Bosch BJ, Lattwein E, Alhakeem RF, Assiri AM, Hajomar W, Albarrak AM, Al-Tawfiq JA, Zumla AI, Memish ZA. 2014. Transmission of MERS-coronavirus in household contacts. N Engl J Med 371:828-835. http://dx.doi.org/10.1056/NEJMoa1405858.
3. Reusken CB, Messadi L, Feyisa A, Ularamu H, Godeke GJ, Danmarwa A, Dawo F, Jemli M, Melaku S, Shamaki D, Woma Y, Wungak Y, Gebremedhin EZ, Zutt I, Bosch BJ, Haagmans BL, Koopmans MP. 2014. Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis 20:1370-1374. http://dx.doi.org/10.3201/eid2008.140590.
4. Chan RW, Hemida MG, Kayali G, Chu DK, Poon LL, Alnaeem A, Ali MA, Tao KP, Ng HY, Chan MC, Guan Y, Nicholls JM, Peiris JS. 2014. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med 2:813-822. http://dx.doi.org/10.1016/S2213-2600(14)70158-4.
5. Corman VM, Ithete NL, Richards LR, Schoeman MC, Preiser W, Drosten C, Drexler JF. 2014. Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol 88:11297-11303. http://dx.doi.org/10.1128/JVI.01498-14.
6. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, Madani TA. 2014. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370:2499-2505. http://dx.doi.org/10.1056/NEJMoa1401505.
7. Hemida MG, Al-Naeem A, Perera RA, Chin A, Poon LM, Peiris M. 12 Feb 2015. Lack of Middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis http://dx.doi.org/10.3201/eid2104.141949.
8. Hui DS, Memish ZA, Zumla A. 2014. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med 20:233-241. http://dx.doi.org/10.1097/MCP.0000000000000046.
9. Peiris JS, Guan Y, Yuen KY. 2004. Severe acute respiratory syndrome. Nat Med 10:S88-97. http://dx.doi.org/10.1038/nm1143.
10. Drexler JF, Corman VM, Drosten C. 2014. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res 101:45-56. http://dx.doi.org/10.1016/j.antiviral.2013.10.013.
11. Hayden FG, Farrar J, Peiris JS. 2014. Towards improving clinical management of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 14:544-546. http://dx.doi.org/10.1016/S1473-3099(14)70793-5.
12. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, Almakhlafi GA, Albarrak MM, Memish ZA, Albarrak AM. 2014. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 14:1090-1095. http://dx.doi.org/10.1016/S1473-3099(14)70920-X.
13. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Beck CR. 2015. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211:80-90. http://dx.doi.org/10.1093/infdis/jiu396.
14. Stockman LJ, Bellamy R, Garner P. 2006. SARS: systematic review of treatment effects. PLoS Med 3:e343. http://dx.doi.org/10.1371/journal.pmed.0030343.
15. Tillib SV, Ivanova TI, Vasilev LA, Rutovskaya MV, Saakyan SA, Gribova IY, Tutykhina IL, Sedova ES, Lysenko AA, Shmarov MM, Logunov DY, Naroditsky BS, Gintsburg AL. 2013. Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2). Antiviral Res 97:245-254. http://dx.doi.org/10.1016/j.antiviral.2012.12.014.
16. Zhao J, Li K, Wohlford-Lenane C, Agnihothram SS, Fett C, Zhao J, Gale MJ, Jr, Baric RS, Enjuanes L, Gallagher T, McCray PB, Jr, Perlman S. 2014. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111:4970-4975. http://dx.doi.org/10.1073/pnas.1323279111.
17. Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY, Wang P, Chu KW, Perlman S, Ali MA, Alnaeem A, Guan Y, Poon LL, Saif L, Peiris M. 2014. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill 19(23):pii=20828. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20828.
18. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y, Li M, Poon LL, Guan Y, Webby RJ, Ali MA, Peiris JS, Kayali G. 2013. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill 18(36):pii=20574. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20574.
19. de Wit E, Rasmussen AL, Falzarano D, Bushmaker T, Feldmann F, Brining DL, Fischer ER, Martellaro C, Okumura A, Chang J, Scott D, Benecke AG, Katze MG, Feldmann H, Munster VJ. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A 110:16598-16603. http://dx.doi.org/10.1073/pnas.1310744110.
20. Falzarano D, de Wit E, Feldmann F, Rasmussen AL, Okumura A, Peng X, Thomas MJ, van Doremalen N, Haddock E, Nagy L, LaCasse R, Liu T, Zhu J, McLellan JS, Scott DP, Katze MG, Feldmann H, Munster VJ. 2014. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog 10:e1004250. http://dx.doi.org/10.1371/journal.ppat.1004250.
21. Agrawal AS, Garron T, Tao X, Peng BH, Wakamiya M, Chan TS, Couch RB, Tseng CT. 14 January 2015. Generation of transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol http://dx.doi.org/10.1128/JVI.03427-14.
22. Cotten M, Watson SJ, Zumla AI, Makhdoom HQ, Palser AL, Ong SH, Al Rabeeah AA, Alhakeem RF, Assiri A, Al-Tawfiq JA, Albarrak A, Barry M, Shibl A, Alrabiah FA, Hajjar S, Balkhy HH, Flemban H, Rambaut A, Kellam P, Memish ZA. 2014. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio 5:e01062-13. http://dx.doi.org/10.1128/mBio.01062-13.
23. Hemida MG, Chu DK, Poon LL, Perera RA, Alhammadi MA, Ng HY, Siu LY, Guan Y, Alnaeem A, Peiris M. 2014. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis 20:1231-1234. http://dx.doi.org/10.3201/eid2007.140571.
24. Adney DR, van Doremalen N, Brown VR, Bushmaker T, Scott D, de Wit E, Bowen RA, Munster VJ. 2014. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis 20:1999-2005. http://dx.doi.org/10.3201/eid2012.141280.
25. Vanlandschoot P, Stortelers C, Beirnaert E, Ibanez LI, Schepens B, Depla E, Saelens X. 2011. Nanobodies(R): new ammunition to battle viruses. Antiviral Res 92:389-407. http://dx.doi.org/10.1016/j.antiviral.2011.09.002.